Quercetin as a possible complementary agent for early-stage COVID-19: Concluding results of a randomized clinical trial

Background: Quercetin, a natural polyphenol with demonstrated broad-spectrum antiviral, anti-inflammatory, and antioxidant properties, has been proposed as an adjuvant for early-stage coronavirus disease 2019 (COVID-19) infection.Objective: To explore the possible therapeutic effect of quercetin in...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Francesco Di Pierro, Amjad Khan, Somia Iqtadar, Sami Ullah Mumtaz, Muhammad Nabeel Akbar Chaudhry, Alexander Bertuccioli, Giuseppe Derosa, Pamela Maffioli, Stefano Togni, Antonella Riva, Pietro Allegrini, Martino Recchia, Nicola Zerbinati
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	Frontiers Media S.A. 2023-01-01
Sarja:	Frontiers in Pharmacology
Aiheet:	Quercetin COVID-19 SARS-CoV-2 Phytosome® Natural Polyphenols 3CL protease inhibition
Linkit:	https://www.frontiersin.org/articles/10.3389/fphar.2022.1096853/full
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!